학술논문

발행년
-
(예 : 2010-2015)
'학술논문' 에서 검색결과 260건 | 목록 1~10
Academic Journal
Bagal SK; Oncology R&D, AstraZeneca, Cambridge CB4 0WG, U.K.; Astles PC; Oncology R&D, AstraZeneca, Cambridge CB4 0WG, U.K.; Diène C; Oncology R&D, AstraZeneca, Cambridge CB4 0WG, U.K.; Argyrou A; Discovery Sciences R&D, AstraZeneca, Cambridge CB4 0WG, U.K.; Crafter C; Oncology R&D, AstraZeneca, Cambridge CB4 0WG, U.K.; Cassar DJ; Oncology R&D, AstraZeneca, Cambridge CB4 0WG, U.K.; Fallan C; Oncology R&D, AstraZeneca, Cambridge CB4 0WG, U.K.; Hock A; Discovery Sciences R&D, AstraZeneca, Cambridge CB4 0WG, U.K.; Jones T; Discovery Sciences R&D, AstraZeneca, Cambridge CB4 0WG, U.K.; Moreau K; Clinical Pharmacology and Safety Sciences, AstraZeneca, Cambridge CB4 0WG, U.K.; Lamont GM; Oncology R&D, AstraZeneca, Cambridge CB4 0WG, U.K.; Lamont S; Oncology R&D, AstraZeneca, Cambridge CB4 0WG, U.K.; Michaloglou C; Oncology R&D, AstraZeneca, Cambridge CB4 0WG, U.K.; Packer MJ; Oncology R&D, AstraZeneca, Cambridge CB4 0WG, U.K.; Pike A; Oncology R&D, AstraZeneca, Cambridge CB4 0WG, U.K.; Ramos-Montoya A; Oncology R&D, AstraZeneca, Cambridge CB4 0WG, U.K.; Scott JS; Oncology R&D, AstraZeneca, Cambridge CB4 0WG, U.K.; Shaw J; Discovery Sciences R&D, AstraZeneca, Cambridge CB4 0WG, U.K.; Shologu Z; Oncology R&D, AstraZeneca, Cambridge CB4 0WG, U.K.
Publisher: American Chemical Society Country of Publication: United States NLM ID: 9716531 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1520-4804 (Electronic) Linking ISSN: 00222623 NLM ISO Abbreviation: J Med Chem Subsets: MEDLINE
Report
Bizzaro F; Laboratory of Cancer Metastasis Therapeutics, Department of Oncology, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Via Mario Negri 2, 20156, Milan, Italy.; Fuso Nerini I; Laboratory of Cancer Metastasis Therapeutics, Department of Oncology, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Via Mario Negri 2, 20156, Milan, Italy.; Laboratory of Cancer Pharmacology, IRCCS Humanitas Research Hospital, Rozzano, Milan, Italy.; Taylor MA; Early Oncology, AstraZeneca, Cambridge, UK.; Anastasia A; Laboratory of Cancer Metastasis Therapeutics, Department of Oncology, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Via Mario Negri 2, 20156, Milan, Italy.; Russo M; Laboratory of Cancer Metastasis Therapeutics, Department of Oncology, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Via Mario Negri 2, 20156, Milan, Italy.; Damia G; Laboratory of Molecular Pharmacology, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Milan, Italy.; Guffanti F; Laboratory of Molecular Pharmacology, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Milan, Italy.; Guana F; Laboratory of Cancer Genomics, Fondazione Edo ed Elvo Tempia Valenta, Biella, Italy.; Ostano P; Laboratory of Cancer Genomics, Fondazione Edo ed Elvo Tempia Valenta, Biella, Italy.; Minoli L; Department of Veterinary Medicine, University of Milan, Milan, Italy.; Hattersley MM; Early Oncology, AstraZeneca, Boston, USA.; Arnold S; Early Oncology, AstraZeneca, Cambridge, UK.; Ramos-Montoya A; Early Oncology, AstraZeneca, Cambridge, UK.; Williamson SC; Early Oncology, AstraZeneca, Cambridge, UK.; Galbiati A; Early Oncology, AstraZeneca, Cambridge, UK.; Urosevic J; Early Oncology, AstraZeneca, Cambridge, UK.; Leo E; Early Oncology, AstraZeneca, Cambridge, UK.; Cavallaro U; Unit of Gynecological Oncology Research, Istituto Europeo di Oncologia IRCCS, Milan, Italy.; Ghilardi C; Laboratory of Cancer Metastasis Therapeutics, Department of Oncology, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Via Mario Negri 2, 20156, Milan, Italy.; Barry ST; Early Oncology, AstraZeneca, Cambridge, UK.; Bani MR; Laboratory of Cancer Metastasis Therapeutics, Department of Oncology, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Via Mario Negri 2, 20156, Milan, Italy. mariarosa.bani@marionegri.it.; Giavazzi R; Laboratory of Cancer Metastasis Therapeutics, Department of Oncology, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Via Mario Negri 2, 20156, Milan, Italy.
Publisher: Biomed Central Country of Publication: England NLM ID: 101468937 Publication Model: Electronic Cited Medium: Internet ISSN: 1756-8722 (Electronic) Linking ISSN: 17568722 NLM ISO Abbreviation: J Hematol Oncol Subsets: MEDLINE
Periodical
Goldberg FW; Oncology R&D, AstraZeneca, Cambridge CB4 0FZ, U.K.; Finlay MRV; Oncology R&D, AstraZeneca, Cambridge CB4 0FZ, U.K.; Ting AKT; Oncology R&D, AstraZeneca, Cambridge CB4 0FZ, U.K.; Beattie D; Oncology R&D, AstraZeneca, Cambridge CB4 0FZ, U.K.; Lamont GM; Oncology R&D, AstraZeneca, Cambridge CB4 0FZ, U.K.; Fallan C; Oncology R&D, AstraZeneca, Cambridge CB4 0FZ, U.K.; Wrigley GL; Oncology R&D, AstraZeneca, Cambridge CB4 0FZ, U.K.; Schimpl M; Discovery Sciences, R&D, AstraZeneca, Cambridge CB4 0FZ, U.K.; Howard MR; Oncology R&D, AstraZeneca, Cambridge CB4 0FZ, U.K.; Williamson B; Oncology R&D, AstraZeneca, Cambridge CB4 0FZ, U.K.; Vazquez-Chantada M; Discovery Sciences, R&D, AstraZeneca, Cambridge CB4 0FZ, U.K.; Barratt DG; Discovery Sciences, R&D, AstraZeneca, Cambridge CB4 0FZ, U.K.; Davies BR; Oncology R&D, AstraZeneca, Cambridge CB4 0FZ, U.K.; Cadogan EB; Oncology R&D, AstraZeneca, Cambridge CB4 0FZ, U.K.; Ramos-Montoya A; Oncology R&D, AstraZeneca, Cambridge CB4 0FZ, U.K.; Dean E; Oncology R&D, AstraZeneca, Cambridge CB4 0FZ, U.K.
Publisher: American Chemical Society Country of Publication: United States NLM ID: 9716531 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1520-4804 (Electronic) Linking ISSN: 00222623 NLM ISO Abbreviation: J Med Chem Subsets: MEDLINE
검색 결과 제한하기
제한된 항목
[검색어] A. Ramos-Montoya
발행연도 제한
-
학술DB(Database Provider)
저널명(출판물, Title)
출판사(Publisher)
자료유형(Source Type)
주제어
언어